Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Treat-to-Target Urate-lowering Therapy: Lessons Learned from the STOP Gout Study.
Journal: Current rheumatology reports
Published: April 16, 2026
Targeted Treatment for Hyperuricemia: The Drug Pipeline.
Journal: Drugs & aging
Published: January 09, 2026
Real-world persistence of urate-lowering therapy following a treat-to-target intervention: A two-year follow-up analysis of the STOP gout trial.
Journal: Seminars in arthritis and rheumatism
Published: May 05, 2025
Improvements in Health-Related Quality of Life With Treat-to-Target Urate-Lowering Therapy in Gout: A Post Hoc Analysis of a Randomized Multicenter Trial.
Journal: Arthritis care & research
Published: February 06, 2025
Long-Term Opioids in Gout: A Matched Cohort Study From the Veterans Health Administration.
Journal: Arthritis care & research
Published: January 04, 2025
Comparison of Gout Flares With the Initiation of Treat-to-Target Allopurinol and Febuxostat: A Post-Hoc Analysis of a Randomized Multicenter Trial.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: February 15, 2024
Determinants of Achieving Serum Urate Goal with Treat-to-Target Urate-Lowering Therapy in Gout.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: August 16, 2023
Efficacy and Safety of Allopurinol and Febuxostat in Patients With Gout and CKD: Subgroup Analysis of the STOP Gout Trial.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation
Published: June 30, 2023
Last Updated: 09/26/2026